Regen BioPharma (RGBP) Times Interest Earned (2016 - 2025)
Historic Times Interest Earned for Regen BioPharma (RGBP) over the last 12 years, with Q3 2025 value amounting to -$1.43.
- Regen BioPharma's Times Interest Earned rose 6637.24% to -$1.43 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.14, marking a year-over-year increase of 6286.3%. This contributed to the annual value of -$2.14 for FY2025, which is 6286.27% up from last year.
- Per Regen BioPharma's latest filing, its Times Interest Earned stood at -$1.43 for Q3 2025, which was up 6637.24% from -$1.65 recorded in Q2 2025.
- In the past 5 years, Regen BioPharma's Times Interest Earned ranged from a high of -$1.07 in Q3 2021 and a low of -$574.2 during Q2 2021
- Moreover, its 5-year median value for Times Interest Earned was -$4.26 (2024), whereas its average is -$44.08.
- Per our database at Business Quant, Regen BioPharma's Times Interest Earned tumbled by 28581681.22% in 2021 and then skyrocketed by 9966.25% in 2022.
- Regen BioPharma's Times Interest Earned (Quarter) stood at -$3.04 in 2021, then tumbled by 779.08% to -$26.72 in 2022, then soared by 74.16% to -$6.9 in 2023, then surged by 64.93% to -$2.42 in 2024, then skyrocketed by 40.88% to -$1.43 in 2025.
- Its Times Interest Earned was -$1.43 in Q3 2025, compared to -$1.65 in Q2 2025 and -$5.08 in Q1 2025.